Zdrowie i gospodarka · 12/02/2020
FDA to Host Public Meeting on Patient-Focused Drug Development for Vitiligo
The FDA is seeking public input on patient perspectives and treatment approaches for vitiligo, a condition that affects daily life, as part of its patient-focused drug development initiative.
Source: Federal Register — Food and Drug AdministrationOpen original release →